비뇨기 기기 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 시술 유형별, 용도별, 최종사용자별, 지역별, 경쟁사별(2019-2029년)

Global Urology Devices Market was valued at USD 33.87 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.14% through 2029. The Global Urology Devices Market encompasses medical devices and equipment used in the diagnosis, treatment, and management of various urological disorders and conditions. Urology devices are designed to address a wide range of urological issues affecting the urinary tract system, kidneys, bladder, prostate, and reproductive organs. The Global Urology Devices Market is driven by factors such as the growing prevalence of urological disorders, aging population, technological advancements in urology devices, increasing demand for minimally invasive procedures, and rising healthcare expenditure worldwide.

Key Market Drivers

Aging Population and Increasing Prevalence of Urological Disorders

The aging demographic worldwide serves as a substantial catalyst propelling the growth of the Global Urology Devices Market. As individuals age, they become more susceptible to a spectrum of urological conditions, including urinary incontinence, kidney stones, benign prostatic hyperplasia (BPH), and urinary tract infections (UTIs). With the elderly population expanding, the prevalence of these urological disorders is anticipated to escalate in tandem, fueling the demand for urology devices. These devices encompass a broad range of tools essential for the diagnosis, treatment, and management of urological conditions, spanning from catheters and stents to cutting-edge surgical instruments utilized in minimally invasive procedures. Consequently, the surging prevalence of urological disorders among the aging demographic emerges as a pivotal driver propelling market growth in the urology devices sector.

Technological Advancements and Innovations in Minimally Invasive Procedures

Technological advancements have brought about a paradigm shift in the realm of urology, ushering in a new era of innovation in diagnosis and treatment modalities. These advancements have propelled the development of cutting-edge devices and techniques that revolutionize the field. Notably, minimally invasive procedures, including laparoscopic and robotic-assisted surgeries, have garnered widespread acclaim for their manifold benefits. These procedures offer patients shorter recovery times, reduced hospital stays, and fewer complications compared to traditional open surgeries, thereby enhancing patient outcomes and satisfaction.

At the forefront of this technological revolution are advanced urology devices designed to facilitate minimally invasive procedures. Robotic surgical systems, laser therapy equipment, and endoscopic instruments are among the innovative devices driving market growth by enabling precision and efficiency in urological interventions. Ongoing research and development endeavors are dedicated to enhancing the precision, efficacy, and safety of urology devices. These efforts aim to further refine existing technologies and introduce novel solutions that address unmet clinical needs, thereby fueling continuous innovation and adoption in the market. As technology continues to evolve, the future of urology holds promise for even more transformative advancements, ultimately improving patient outcomes and shaping the landscape of urological care.

Increasing Healthcare Expenditure and Demand for Advanced Treatment Options

The uptick in healthcare spending, alongside heightened awareness of urological conditions and their treatment alternatives, stands as a pivotal driver propelling the demand for cutting-edge urology devices. Patients are actively seeking out minimally invasive treatment options, recognizing their potential to deliver superior clinical outcomes while enhancing overall quality of life. Consequently, healthcare providers are responding to this shift in patient preferences by making substantial investments in state-of-the-art urology devices. These investments are geared towards meeting the evolving needs and expectations of patients, thereby enhancing the overall quality of care provided. Moreover, the presence of favorable reimbursement policies for urological procedures and devices in various regions serves as an additional incentive for healthcare facilities to invest in advanced technologies. This supportive reimbursement landscape further amplifies market growth, encouraging the adoption of innovative urology devices and reinforcing the trajectory of advancement within the sector.

Growing Prevalence of Chronic Kidney Diseases and Urinary Tract Infections

Chronic kidney diseases (CKD) and urinary tract infections (UTIs) represent prevalent and burdensome conditions on a global scale, significantly contributing to the burgeoning demand for urology devices. CKD, characterized by a gradual decline in kidney function over time, necessitates continuous management and treatment to mitigate potential complications, including kidney failure. In this regard, urology devices such as dialysis machines, catheters, and nephrostomy tubes play an indispensable role in the comprehensive care and treatment regimen for CKD patients.

Similarly, UTIs, stemming from bacterial infections within the urinary tract, present as common ailments that often require prompt intervention. Treatment typically involves a combination of antibiotics and the utilization of urinary catheters to alleviate symptoms and eradicate the underlying infection. As the global prevalence of both CKD and UTIs continues to escalate, fueled by factors such as aging populations and lifestyle-related risk factors, the demand for urology devices tailored for the diagnosis, management, and treatment of these conditions is poised to surge correspondingly. This anticipated rise underscores the critical role of urology devices in addressing the evolving healthcare needs of individuals affected by CKD and UTIs, reaffirming their significance in the healthcare landscape.

Key Market Challenges

Reimbursement Limitations and Pricing Pressures

Reimbursement limitations and pricing pressures present formidable hurdles for the Global Urology Devices Market, particularly concerning novel and high-value devices. Variances in healthcare reimbursement policies among different systems and payer organizations lead to discrepancies in coverage and reimbursement rates for urological procedures and devices. This inconsistency complicates market dynamics and can hinder widespread adoption of innovative technologies.

The imposition of stringent cost-containment measures by healthcare payers and providers exerts downward pressure on device pricing. This impacts manufacturers' profit margins and revenue streams, posing challenges for sustaining research and development efforts and hindering investment in future innovations. The reimbursement process itself is intricate and time-consuming, often involving extensive paperwork and negotiations. This bureaucratic complexity adds administrative burdens and contributes to delays in reimbursement for healthcare providers. Such delays can impede investment in advanced urology devices and deter healthcare facilities from adopting cutting-edge technologies.

Technological Complexity and Integration Issues

The evolving landscape of urology devices is characterized by technological complexity and integration challenges, which can hinder seamless interoperability and adoption of new technologies. As urology devices become increasingly sophisticated and interconnected, compatibility issues may arise when integrating multiple devices or systems within healthcare facilities. The rapid pace of technological innovation in areas such as robotics, artificial intelligence, and digital health introduces new complexities related to device interoperability, data management, and cybersecurity. Healthcare providers often face challenges in effectively integrating and leveraging these advanced technologies to optimize patient care and clinical workflows. Moreover, the need for specialized training and technical support to operate and maintain complex urology devices further compounds integration challenges, necessitating ongoing education and support initiatives for healthcare professionals.

Key Market Trends

Growing Incidence of Urological Cancers

Urological cancers, encompassing prostate cancer, bladder cancer, and kidney cancer, stand as formidable health challenges on a global scale. The incidence of these malignancies is witnessing an upward trajectory, propelled by various factors including demographic shifts, lifestyle modifications, and environmental influences. Given the potential for adverse outcomes associated with these cancers, early detection and prompt intervention are imperative to enhance patient prognosis and survival rates.

Urology devices emerge as indispensable tools in the armamentarium against urological cancers. Devices such as biopsy needles, imaging systems, and surgical instruments play pivotal roles in facilitating the comprehensive management of these malignancies, spanning from accurate diagnosis and staging to tailored treatment strategies. By enabling healthcare professionals to conduct precise and targeted interventions, urology devices contribute significantly to improving patient outcomes and optimizing therapeutic efficacy.

Increasing Adoption of Telemedicine and Remote Patient Monitoring

The COVID-19 pandemic has served as a catalyst for the widespread adoption of telemedicine and remote patient monitoring solutions across the healthcare landscape. This transformative shift is particularly pronounced within the field of urology, where telemedicine platforms have emerged as indispensable tools for delivering comprehensive care amidst social distancing measures and restrictions on in-person medical appointments. By facilitating remote consultations, follow-up visits, and continuous monitoring of patients with chronic urological conditions, telemedicine has revolutionized the delivery of urological care, ensuring uninterrupted access to essential healthcare services.

In tandem with the rise of telemedicine, the demand for urology devices designed for home-based use has surged. These devices, including home-based urinary catheters, bladder scanners, and uroflowmetry systems, play a pivotal role in supporting remote patient monitoring initiatives. Through the seamless integration of such devices into telemedicine platforms, healthcare providers can remotely assess patients' urological health parameters, monitor treatment progress, and intervene promptly in case of any concerning developments. The inherent convenience, safety, and efficiency afforded by telemedicine and remote patient monitoring solutions have garnered widespread acclaim among both healthcare professionals and patients alike, fueling their rapid adoption across the healthcare continuum.

Segmental Insights

TypeInsights

Based on the type, endoscopes are emerging as the dominant force in the Global Urology Devices Market, revolutionizing diagnostic and therapeutic procedures for various urological conditions. These sophisticated devices play a pivotal role in visualizing and accessing the urinary tract, offering healthcare professionals invaluable insights into the anatomy and pathology of urological structures. With advancements in technology, endoscopes have evolved to provide high-definition imaging, enhanced manoeuvrability, and greater procedural versatility.

Endoscopic procedures, such as cystoscopy, ureteroscopy, and nephoscopy, have become standard practices in urology for diagnosing and treating a myriad of conditions, including kidney stones, bladder tumours, and urethral strictures. The minimally invasive nature of endoscopic techniques minimizes patient discomfort, accelerates recovery times, and reduces the risk of complications compared to traditional open surgeries. The integration of innovative features such as digital imaging systems, flexible and semi-rigid scopes, and laser fibre compatibility has expanded the scope and capabilities of endoscopic procedures in urology. Laser and lithotripsy devices, in particular, complement endoscopic techniques by facilitating the fragmentation and removal of urinary calculi with precision and efficiency.

Procedure Type Insights

Based on the procedure type segment, robotic surgery has emerged as the dominant force, revolutionizing the landscape of urological procedures with its precision, dexterity, and enhanced surgical capabilities. Robotic surgery systems, such as the da Vinci Surgical System, have transformed minimally invasive surgery by providing surgeons with advanced robotic-assisted tools and a three-dimensional, high-definition visualization platform.

Robotic surgery offers numerous advantages over traditional open and laparoscopic techniques, including improved surgical precision, reduced blood loss, shorter hospital stays, and faster recovery times. These benefits are particularly significant in urology, where complex anatomical structures and delicate tissues require meticulous surgical manipulation. One of the key factors driving the dominance of robotic surgery in urology is its versatility across a wide range of urological procedures, including prostatectomy, cystectomy, nephrectomy, and pyeloplasty. The intuitive interface and ergonomic design of robotic surgical systems enable surgeons to perform intricate manoeuvres with enhanced dexterity and control, leading to superior surgical outcomes and reduced risk of complications.

Regional Insights

North America stands out as the dominant region, spearheading advancements, innovations, and widespread adoption of urological technologies. Several factors contribute to North America's leading position in this market. North America boasts a robust healthcare infrastructure characterized by state-of-the-art medical facilities, renowned research institutions, and a well-established regulatory framework.

The region's advanced healthcare system fosters a conducive environment for the development and commercialization of urology devices, attracting investment and driving innovation. The prevalence of urological disorders in North America is significant, with conditions such as urinary incontinence, kidney stones, prostate cancer, and urinary tract infections affecting a substantial portion of the population. The high disease burden necessitates the availability of advanced diagnostic and therapeutic solutions, driving demand for urology devices in the region.

Key Market Players

Boston Scientific Corporation

Fresenius Medical Care AG Co. KgaA

Baxter International Inc.

Becton, Dickinson, and Company

Olympus Corporation

B. Braun Melsungen AG

Medtronic Plc

Stryker Corporation

Teleflex Incorporated

Cook Medical, Inc.

Report Scope:

In this report, the Global Urology Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Urology Devices Market,By Type:

• Endoscopes
• Dialysis Devices
• Laser Lithotripsy Devices
• Endovision Imaging Devices
• Catheters
• Urodynamic Systems
• Stents
• Biopsy Devices
• Others

Urology Devices Market,By Procedure Type:

• Minimally Invasive Surgery Devices
• Robotic Surgery

Urology Devices Market,By Application:

• Kidney Diseases
• Urological Cancer BPH
• Pelvic Organ Prolapse
• Others

Urology Devices Market,By End User:

• Hospitals Clinics
• Ambulatory Care Centers
• Dialysis Centers
• Home Care Settings

Urology Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Urology Devices Market.

Available Customizations:

Global Urology Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validations
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Urology Devices Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Type (Endoscopes, Dialysis Devices, Laser Lithotripsy Devices, Endovision Imaging Devices, Catheters, Urodynamic Systems, Stents, Biopsy Devices, Others)
  • 5.2.2.By Procedure Type (Minimally Invasive Surgery Devices and Robotic Surgery)
  • 5.2.3.By Application (Kidney Diseases, Urological Cancer BPH, Pelvic Organ Prolapse, Others)
  • 5.2.4.By End User (Hospitals Clinics, Ambulatory Care Centers, Dialysis Centers, Home Care Settings)
  • 5.2.5.By Region
  • 5.2.6.By Company (2023)
• 5.3.Market Map

6.North America Urology Devices Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.ByType
  • 6.2.2.By Procedure Type
  • 6.2.3.By Application
  • 6.2.4.ByEnd User
  • 6.2.5.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Urology Devices Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Type
      • 6.3.1.2.2.By Procedure Type
      • 6.3.1.2.3.By Application
      • 6.3.1.2.4.By End User
  • 6.3.2.Canada Urology Devices Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Type
      • 6.3.2.2.2.By Procedure Type
      • 6.3.2.2.3.By Application
      • 6.3.2.2.4.By End User
  • 6.3.3.Mexico Urology Devices Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Type
      • 6.3.3.2.2.By Procedure Type
      • 6.3.3.2.3.By Application
      • 6.3.3.2.4.By End User

7.Europe Urology Devices Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Type
  • 7.2.2.By Procedure Type
  • 7.2.3.By Application
  • 7.2.4.By End User
  • 7.2.5.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.Germany Urology Devices Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Type
      • 7.3.1.2.2.By Procedure Type
      • 7.3.1.2.3.By Application
      • 7.3.1.2.4.By End User
  • 7.3.2.United Kingdom Urology Devices Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Type
      • 7.3.2.2.2.By Procedure Type
      • 7.3.2.2.3.By Application
      • 7.3.2.2.4.By End User
  • 7.3.3.Italy Urology Devices Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecasty
      • 7.3.3.2.1.By Type
      • 7.3.3.2.2.By Procedure Type
      • 7.3.3.2.3.By Application
      • 7.3.3.2.4.By End User
  • 7.3.4.France Urology Devices Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Type
      • 7.3.4.2.2.By Procedure Type
      • 7.3.4.2.3.By Application
      • 7.3.4.2.4.By End User
  • 7.3.5.Spain Urology Devices Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Type
      • 7.3.5.2.2.By Procedure Type
      • 7.3.5.2.3.By Application
      • 7.3.5.2.4.By End User

8.Asia-Pacific Urology Devices Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Type
  • 8.2.2.By Procedure Type
  • 8.2.3.By Application
  • 8.2.4.By End User
  • 8.2.5.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.China Urology Devices Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Type
      • 8.3.1.2.2.By Procedure Type
      • 8.3.1.2.3.By Application
      • 8.3.1.2.4.By End User
  • 8.3.2.India Urology Devices Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Type
      • 8.3.2.2.2.By Procedure Type
      • 8.3.2.2.3.By Application
      • 8.3.2.2.4.By End User
  • 8.3.3.Japan Urology Devices Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Type
      • 8.3.3.2.2.By Procedure Type
      • 8.3.3.2.3.By Application
      • 8.3.3.2.4.By End User
  • 8.3.4.South Korea Urology Devices Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Type
      • 8.3.4.2.2.By Procedure Type
      • 8.3.4.2.3.By Application
      • 8.3.4.2.4.By End User
  • 8.3.5.Australia Urology Devices Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Type
      • 8.3.5.2.2.By Procedure Type
      • 8.3.5.2.3.By Application
      • 8.3.5.2.4.By End User

9.South America Urology Devices Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Type
  • 9.2.2.By Procedure Type
  • 9.2.3.By Application
  • 9.2.4.By End User
  • 9.2.5.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Urology Devices Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Type
      • 9.3.1.2.2.By Procedure Type
      • 9.3.1.2.3.By Application
      • 9.3.1.2.4.By End User
  • 9.3.2.Argentina Urology Devices Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Type
      • 9.3.2.2.2.By Procedure Type
      • 9.3.2.2.3.By Application
      • 9.3.2.2.4.By End User
  • 9.3.3.Colombia Urology Devices Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Type
      • 9.3.3.2.2.By Procedure Type
      • 9.3.3.2.3.By Application
      • 9.3.3.2.4.By End User

10.Middle East and Africa Urology Devices Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Type
  • 10.2.2.By Procedure Type
  • 10.2.3.By Application
  • 10.2.4.By End User
  • 10.2.5.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Urology Devices Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Type
      • 10.3.1.2.2.By Procedure Type
      • 10.3.1.2.3.By Application
      • 10.3.1.2.4.By End User
  • 10.3.2.Saudi Arabia Urology Devices Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Type
      • 10.3.2.2.2.By Procedure Type
      • 10.3.2.2.3.By Application
      • 10.3.2.2.4.By End User
  • 10.3.3.UAE Urology Devices Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Type
      • 10.3.3.2.2.By Procedure Type
      • 10.3.3.2.3.By Application
      • 10.3.3.2.4.By End User

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Merger Acquisition (If Any)
• 12.2.Product Launches (If Any)
• 12.3.Recent Developments

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Products

14.Competitive Landscape

• 14.1.Boston Scientific Corporation
  • 14.1.1.Business Overview
  • 14.1.2.Company Snapshot
  • 14.1.3.Products Services
  • 14.1.4.Financials (As Reported)
  • 14.1.5.Recent Developments
  • 14.1.6.Key Personnel Details
  • 14.1.7.SWOT Analysis
• 14.2.Fresenius Medical Care AG Co. KgaA
• 14.3.Baxter International Inc.
• 14.4.Becton, Dickinson, and Company
• 14.5.Olympus Corporation
• 14.6.B. Braun Melsungen AG
• 14.7.Medtronic Plc
• 14.8.Stryker Corporation
• 14.9.Teleflex Incorporated
• 14.10.Cook Medical, Inc.

15.Strategic Recommendations

16.About Us Disclaimer